Bck Capital Management LP F Star Therapeutics, Inc. Transaction History

Bck Capital Management LP

  • $273 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
BUY
$4.09 - $6.86 $349,527 - $586,248
85,459 Added 164.34%
137,459 $868,000
Q2 2022

Aug 08, 2022
BUY
$2.18 - $6.39 $113,360 - $332,280
52,000 New
52,000 $326,000

Others Institutions Holding FSTX

# of Institutions
3
Shares Held
44.7K
Call Options Held
0
Put Options Held
0
View Full List

About F-star Therapeutics, Inc.

FSTX Quotes by TradingView
  • Ticker FSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,584,700
  • Description
  • F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...
More about FSTX
Track This Portfolio

Track Bck Capital Management LP Portfolio

Follow Bck Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bck Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Bck Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email